Polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion.
作者信息
Okauchi Shinichiro, Kagohashi Katsunori, Shiozawa Toshihiro, Miyazaki Kunihiko, Satoh Hiroaki
机构信息
Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Ryugasaki, Japan. E-mail:
Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital, Ryugasaki, Japan.
出版信息
Ann Thorac Med. 2020 Jul-Sep;15(3):182. doi: 10.4103/atm.ATM_172_20. Epub 2020 Jun 18.
Abstract
摘要
相似文献
1
Polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion.多形核白细胞增多型和淋巴细胞增多型结核性胸腔积液。
Ann Thorac Med. 2020 Jul-Sep;15(3):182. doi: 10.4103/atm.ATM_172_20. Epub 2020 Jun 18.
2
Clinical and pathological differences between polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion.多形核白细胞增多型与淋巴细胞增多型结核性胸腔积液的临床及病理差异
Ann Thorac Med. 2020 Apr-Jun;15(2):76-83. doi: 10.4103/atm.ATM_15_20. Epub 2020 Apr 3.
3
Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions.中性粒细胞和淋巴细胞丰富型结核性胸腔积液的比较。
Int J Tuberc Lung Dis. 2013 Jan;17(1):85-9. doi: 10.5588/ijtld.12.0236. Epub 2012 Nov 15.
4
Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers.结核分枝杆菌与中性粒细胞性胸腔积液：发生率和临床特征。
Respir Med. 2009 Jun;103(6):820-6. doi: 10.1016/j.rmed.2008.12.023. Epub 2009 Feb 12.
5
6
[T-lymphocyte subsets in peripheral blood and pleural effusion in tuberculous pleurisy and carcinomatous pleurisy: analysis by monoclonal antibodies].
Zhonghua Jie He He Hu Xi Za Zhi. 1989 Apr;12(2):96-8, 127.
7
Age and sex distribution in malignant and tuberculous serous effusions: A study of 127 patients and review of the literature.恶性和结核性浆液性积液的年龄及性别分布：127例患者的研究及文献综述
Geriatr Gerontol Int. 2015 Sep;15(9):1143-50. doi: 10.1111/ggi.12412. Epub 2014 Nov 19.
8
Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura.结核性胸腔积液：腺苷脱氨酶（ADA）活性与胸腔积液及胸膜中的CD4 +细胞数量相关。
Respiration. 2005 Mar-Apr;72(2):160-5. doi: 10.1159/000084047.
9
[Lymphocyte chemotactic factor in tuberculous pleural effusion].[结核性胸腔积液中的淋巴细胞趋化因子]
Kekkaku. 1998 Apr;73(4):307-14.
10
[Determination and significance of interleukin-16 in tuberculous and malignant pleural effusion].[结核性与恶性胸腔积液中白细胞介素-16的测定及意义]
Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):199-201.
本文引用的文献
1
Clinical and pathological differences between polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion.多形核白细胞增多型与淋巴细胞增多型结核性胸腔积液的临床及病理差异
Ann Thorac Med. 2020 Apr-Jun;15(2):76-83. doi: 10.4103/atm.ATM_15_20. Epub 2020 Apr 3.
2
VATS and Intrapleural Fibrinolytic Therapy for Parapneumonic Empyema.电视辅助胸腔镜手术及胸膜内纤维蛋白溶解疗法治疗肺炎旁胸腔积液
Ann Thorac Cardiovasc Surg. 2018 Oct 19;24(5):263-264. doi: 10.5761/atcs.lte.18-00092. Epub 2018 Jul 2.
3
Tuberculous pleural effusions: advances and controversies.结核性胸腔积液：进展与争议
J Thorac Dis. 2015 Jun;7(6):981-91. doi: 10.3978/j.issn.2072-1439.2015.02.18.
4
[Lymphocyte chemotactic factor in tuberculous pleural effusion].[结核性胸腔积液中的淋巴细胞趋化因子]
Kekkaku. 1998 Apr;73(4):307-14.
Zotero 插件